bioRxiv · 10.1101/2020.09.01.277954
Angiotensin converting enzyme 2 is a novel target of the γ-secretase complex
Abstract
Angiotensin converting enzyme 2 (ACE2) is a key regulator of the renin-angiotensin system, but also the functional receptor of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Based on structural similarity with other {gamma}-secretase ({gamma}S) targets, we hypothesized that ACE2 may be affected by {gamma}S proteolytic activity. We found that after ectodomain shedding, ACE2 is targeted for intramembrane proteolysis by {gamma}S, releasing a soluble ACE2 C-terminal fragment. Consistently, chemical or genetic inhibition of {gamma}S results in the accumulation of a membrane-bound fragment of ectodomain-deficient ACE2. Although chemical inhibition of {gamma}S does not alter SARS-CoV-2 cell entry, these data point to a novel pathway for cellular ACE2 trafficking.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Bartolome, A., Liang, J., Wang, P., Ho, D. D., Pajvani, U. B.. 2020-09-03. Angiotensin converting enzyme 2 is a novel target of the γ-secretase complex. https://doi.org/10.1101/2020.09.01.277954
Cite the original work for its findings. Save a collection to share your selection of sources.